Site icon pharmaceutical daily

Dementia Global Clinical Trials Review 2021, Featuring Eisai, Johnson & Johnson, Novartis, Eli Lilly and AstraZeneca – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Dementia – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering.

The clinical trial report provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia .

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

Companies Mentioned

Key Topics Covered:

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/jh4jgt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version